Laboratory Corporation of America(R) Holdings Announces Offering Of Zero Coupon Convertible Subordinated Notes

BURLINGTON, N.C., Sep 4, 2001 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced its intention, subject to market and other conditions, to raise approximately $435 million (excluding proceeds of an overallotment option, if any) through a private

Alpha Therapeutic Forms Alliance for Plasma Testing Laboratory; Agreement With National Genetics Institute and LabCorp Enhances Testing Operations

LOS ANGELES, Aug 28, 2001 (BW HealthWire) -- Alpha Therapeutic Corporation announced today that it has formed a laboratory management alliance with National Genetics Institute (NGI), a subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), in which NGI/LabCorp will

Laboratory Corporation of America(R) Announces Second Quarter Results; Continued Price and Volume Gains Generate Record Profits

BURLINGTON, N.C., Jul 23, 2001 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for the quarter ended June 30, 2001. Second Quarter Results Net sales were $549.7 million, operating income was $102.6 million, and net income was $52.1

EXACT Sciences and Laboratory Corporation of America Sign Licensing Agreement For Testing Services Based Upon EXACT Sciences' Genomics-Based Technologies

BURLINGTON, N.C., July 11 /PRNewswire/ -- EXACT Sciences Corporation (Nasdaq: EXAS) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that they have signed an agreement for the licensing of EXACT Sciences' proprietary genomics- based technologies to LabCorp.

LabCorp(R) Scheduled to Present at Goldman, Sachs & Co. Healthcare Conference

BURLINGTON, N.C., Jun 12, 2001 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the Goldman, Sachs & Co. Healthcare Conference in Dana Point, CA on

LabCorp(R) Acquires ViroMed Inc.

BURLINGTON, N.C., June 4 /PRNewswire/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced that it has completed the acquisition of Minneapolis-based ViroMed Inc. ViroMed had clinical laboratory revenues for the twelve months ended December 31, 2000 of approximately

Roche to Sell Up to 6.0 Million Shares of LabCorp

BURLINGTON, N.C., May 10 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the offering by Roche Holdings, Inc.

LabCorp(R) Scheduled to Present at Deutsche Banc Alex. Brown Health Care Conference

BURLINGTON, N.C., May 8 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Deutsche Banc Alex. Brown Health Care Conference in Baltimore, MD on Tuesday,

Laboratory Corporation of America(R) Completes Acquisition of Path Lab

BURLINGTON, N.C., May 1 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that it has completed the acquisition of New England-based Path Lab Holdings, Inc. (Path Lab). Path Lab had revenues in 2000 of approximately $51.6 million and earnings

Laboratory Corporation of America(R) Announces First Quarter Results

Reports Record Profits Driven by Strong Sales; Announces Two-for-One Stock Split BURLINGTON, N.C., April 23 /PRNewswire Interactive News Release/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2001.